Right Ventricular Function at Rest in Highlanders/Lowlanders

Sponsor
University of Zurich (Other)
Overall Status
Completed
CT.gov ID
NCT03165656
Collaborator
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov (Other)
173
1
2.8
62.7

Study Details

Study Description

Brief Summary

The purpose of the current study is to evaluate the progression of right ventricular function and dimension in Kyrgyz highlanders with high altitude pulmonary hypertension (HAPH) by performing a cross sectional case-control study.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    173 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Right Ventricular Function at Rest in Highlanders With Pulmonary Hypertension Compared to Highlanders Without Pulmonary Hypertension and Lowlanders
    Actual Study Start Date :
    May 24, 2017
    Actual Primary Completion Date :
    Aug 16, 2017
    Actual Study Completion Date :
    Aug 16, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    High altitude pulmonary hypertension

    Highlanders with high altitude pulmonary hypertension living above 2500 m.

    High altitude control

    Healthy highlanders living above 2500 m.

    Low altitude control

    Healthy lowlanders living below 1000 m.

    Outcome Measures

    Primary Outcome Measures

    1. Pulmonary artery pressure [Day 2]

      Difference between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders in tricuspid pressure gradient, measured by transthoracic echocardiography

    Secondary Outcome Measures

    1. cardiac output [Day 2]

      Difference between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders in cardiac output, measured by transthoracic echocardiography

    2. right heart dimensions [Day 2]

      Difference of right heart dimensions between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders, measured by transthoracic echocardiography

    3. Right heart function [Day 2]

      Differences of right heart function between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders, measured by transthoracic echocardiography (TAPSE)

    4. stroke volume [Day 2]

      Difference between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders in stroke volume, measured by transthoracic echocardiography

    5. volumes [Day 2]

      Difference of volumes between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders, measured by transthoracic echocardiography

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    16 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • high altitude pulmonary hypertension confirmed by clinical presentation and mean pulmonary artery pressure >30 mmHg measured by echocardiography at altitude of residence.

    • healthy subjects (high altitude controls)

    • Both genders

    • Age >16 y

    • Kyrgyz ethnicity

    • born, raised and currently living at >2500 m

    • healthy subjects currently living at <1000 m (low altitude controls)

    Exclusion Criteria:
    • Pulmonary hypertension from other causes, in particular from left ventricular failure as judged clinically and by echocardiography

    • Excessive erythrocytosis

    • Other coexistent disorders that may interfere with the cardio-respiratory system and sleep

    • Regular use of medication that affects control of breathing

    • Heavy smoking

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Center for Cardiology and Internal Medicine Bishkek Kyrgyzstan 720040

    Sponsors and Collaborators

    • University of Zurich
    • National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov

    Investigators

    • Study Chair: Talant M Sooronbaev, MD, National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Silvia Ulrich Somaini, Prof. Dr., University of Zurich
    ClinicalTrials.gov Identifier:
    NCT03165656
    Other Study ID Numbers:
    • 01-8/433A
    First Posted:
    May 24, 2017
    Last Update Posted:
    Aug 16, 2019
    Last Verified:
    Aug 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Silvia Ulrich Somaini, Prof. Dr., University of Zurich
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 16, 2019